May Measurement Month 2017: an analysis of blood pressure screening results worldwide

Autor: Thomas Beaney, MRCP, Aletta E Schutte, PhD, Maciej Tomaszewski, MD, Cono Ariti, MSc, Louise M Burrell, MD, Rafael R Castillo, FPCP, Fadi J Charchar, PhD, Albertino Damasceno, PhD, Ruan Kruger, PhD, Daniel T Lackland, DrPH, Peter M Nilsson, MD, Dorairaj Prabhakaran, DM, Agustin J Ramirez, MD, Markus P Schlaich, MD, Jiguang Wang, PhD, Michael A Weber, MD, Neil R Poulter, FMed Sci, C Napiza-Granada, Ma. RC Sevilla, AA Atilano, DID Ona, A More, AP Jose, A Maheshwari, D Kondal, W Yu, W Li, S Xu, J Yu, H Zhang, B Widyantoro, Y Turana, TD Situmorang, Y Sofiatin, R Barack, H-J Lin, T-D Wang, W-J Chen, Y Sirenko, O Evstigneeva, E Negresku, ME Yousif, SA Medani, HM Beheiry, IA Ali, JM Zilberman, MJ Marin, PD Rodriguez, F Garcia-Vasquez, KE Kramoh, D Ekoua, P Lopez-Jaramillo, J Otero, G Sanchez, C Narvaez, JL Accini, R Hernandez-Hernandez, JA Octavio, I Morr, J Lopez-Rivera, D Ojji, A Arije, A Babatunte, KW Wahab, M Fernandes, SV Pereira, M Valentim, A Dzudie, S Kingue, DA Djomou Ngongang, EN Ogola, FA Barasa, B Gitura, F-T-N Malik, SR Choudhury, MA Al Mamun, VH Minh, NL Viet, S Cao Truong, C Ferri, G Parati, C Torlasco, C Borghi, FM Goma, C Syatalimi, PH Zelveian, E Barbosa, W Sebba Barroso, E Penaherrera, E Jarrin, A Yusufali, N Bazargani, B Tsinamdzgvrishvili, D Trapaidze, D Neupane, SR Mishra, J Jozwiak, J Malyszko, A Konradi, I Chazova, M Ishaq, F Memon, AM Heagerty, J Keitley, AJB Brady, JR Cockcroft, BJ McDonnell, F Lanas, Y-C Chia, H Ndhlovu, I Kiss, LM Ruilope, BF Ellenga Mbolla, AS Milhailidou, AJ Woodiwiss, S Perl, E Dolan, V Azevedo, L Garre, JG Boggia, VWY Lee, S Kowlessur, M Miglinas, D Sukackiene, RD Wainford, D Habonimana, T Masupe, J Ortellado, G Wuerzner, L Alcocer, G Burazeri, E Sanchez Delgado, D Lovic, CK Mondo, A Mostafa, SK Nadar, O Valdez Tiburcio, A Leiba, M Dorobantu, T De Backer, J Chifamba, G Stergiou, CR Nwokocha, S Sokolovic, AI Toure, KL Connell, NA Khan, D Burger, M De Carvalho Rodrigues, BK Kramer, RE Schmieder, T Unger, FS Wyss, NV Yameogo, H Beistline, JG Kenerson, B Alfonso, MH Olsen, M Soares

Publikováno v: The Lancet Global Health, Vol 6, Iss 7, Pp e736-e743 (2018)

Summary: Background: Increased blood pressure is the biggest contributor to the global burden of disease and mortality. Data suggest that less than half of the population with hypertension is aware of it. May Measurement Month was initiated to raise

Externí odkaz: https://doaj.org/article/a6638f33053b4e79affdf5d3b6c3c273

DOES USE OF ANTIHYPERTENSIVE TREATMENT TO REDUCE ALBUMINURIA TRANSLATE INTO EFFECTIVE BENEFITS ON OUTCOME AND MORTALITY? A REAPPRAISAL OF STUDIES WITH RENAL ENDPOINTS IN DIABETES: PP.16.105

Autor: G. Mancia, J Chalmers, LM Ruilope

Publikováno v: Journal of Hypertension. 28:e281

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38d269e637c49af21e09aed60c6d90fb
https://doi.org/10.1097/01.hjh.0000379031.35224.c0

EARLY BLOOD PRESSURE CONTROL BY THE NIFEDIPINE GITS/TELMISARTAN COMBINATION: PP.33.314

Autor: G Mancia, G Parati, G Bilo, LM Ruilope

Publikováno v: Journal of Hypertension. 28:e544

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1037d98b2c7f280da5b337192332f75
https://doi.org/10.1097/01.hjh.0000379852.43006.8a

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial

Autor: LM Ruilope, J Segura

Publikováno v: The Lancet. 374:26

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::39e1fc956c77b2bfd638d9bf2ead45a1
https://doi.org/10.1016/s0140-6736(09)61233-2

Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle

Autor: Garcia-Robles R, Lm, Ruilope, Tovar J, de Pablos P, Parada J, Hurtado A, Blanca Miranda, Fernandez Vazquez G, Jl, Rodicio, Sancho J

Publikováno v: Europe PubMed Central

A group of eight normotensive female volunteers with regular menstrual cycles were studied during two menstrual cycles: a control cycle and one in which they received lisuride, a D1-D2 dopamine agonist (0.025 mg/8 hr). The following tests were perfor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dc86827775c75c2c84dbd4f09b574b96
https://pubmed.ncbi.nlm.nih.gov/3134515